Esther M. de Kruijf

Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients

Esther M. de Kruijf, Johanna G. H. van Nes, Cornelis J.�H. van de Velde et al. · Breast Cancer Research and Treatment · 2010 · 286 citations · Full text

Medicine, Cancer Biology, Oncology +15

HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients

Esther M. de Kruijf, Anita Sajet, Johanna G. H. van Nes et al. · The Journal of Immunology · 2010 · 263 citations · Full text

Life Sciences, Immunology, Oncology +16

TRAF4 Promotes TGF-β Receptor Signaling and Drives Breast Cancer Metastasis

Long Zhang, Fangfang Zhou, Amaya García de Vinuesa et al. · Molecular Cell · 2013 · 225 citations · Full text

Medicine, Molecular Biology, Oncology +14

NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study

Esther M. de Kruijf, Anita Sajet, Johanna GH van Nes et al. · BMC Cancer · 2012 · 126 citations · Full text

Life Sciences, Immunology, Oncology +17

The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients with Early Breast Cancer

Esther M. de Kruijf, Johanna G. H. van Nes, Anita Sajet et al. · Clinical Cancer Research · 2010 · 110 citations · Full text

Life Sciences, Immunology, Oncology +17